Last edition
News about "Morgan Stanley Private Equity Asia "
Maiva Pharma Raises INR 1,000 Crore from Fundraising
Maiva Pharma has secured INR 1,000 crore in primary and secondary funding from a fund managed by Morgan Stanley Private Equity Asia and India Life Sciences Fund – IV (ILSF – IV).
Morgan Stanley Private Equity Asia | 03/05/2024 | By Aishwarya | 275
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members